v2.4.0.6
Condensed Balance Sheets (USD $)
Nov. 30, 2012
Feb. 29, 2012
ASSETS    
Cash and cash equivalents $ 149,720 $ 3,014
Total current assets 149,720 3,014
Long term assets:    
Cash and cash equivalents held in trust 42,740,000 0
Accrued interest on cash and cash equivalents held in trust 22,027 0
Deferred offering costs associated with Public Offering 0 156,722
Total long term assets 42,762,027 156,722
Total assets 42,911,747 159,736
LIABILITIES AND SHAREHOLDERS' EQUITY    
Note payable to shareholder 0 100,000
Accounts payable 38,840 52,063
Total liabilities 38,840 152,063
COMMITMENTS      
Ordinary shares, subject to possible conversion, 3,674,999 shares at conversion value 37,397,490 0
Shareholders' equity    
Preferred shares, $0.0001 par value, 1,000,000 authorized shares and no outstanding shares 0 0
Ordinary shares, $0.0001 par value, 100,000,000 authorized shares; 1,575,001 and 1,050,001 issued and outstanding shares, respectively (which excludes 3,674,999 shares subject to possible conversion) (1)(2) 158 [1],[2] 105 [1],[2]
Additional paid-in capital 5,790,425 24,895
Deficit accumulated during the development stage (315,166) (17,327)
Total shareholders' equity 5,475,417 7,673
Total liabilities and shareholders' equity $ 42,911,747 $ 159,736
[1] Share amounts have been retroactively restated to reflect the contribution to the Company of 287,500 ordinary shares by the Initial Shareholders on March 9, 2012 (Note 9).
[2] Reflects an aggregate of 100,000 shares forfeited by the Initial Shareholders on May 1, 2012 because the underwriters' over-allotment option was not exercised in full (Note 9).